Nirvana Life Sciences (XCNQ:NIRV) Net Issuance of Preferred Stock : C$0.00 Mil (TTM As of Jan. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Nirvana Life Sciences Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Nirvana Life Sciences's net issuance of preferred for the three months ended in Jan. 2024 was C$0.00 Mil. The number is 0, which means that Nirvana Life Sciences has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Nirvana Life Sciences's net issuance of preferred for the trailing twelve months (TTM) ended in Jan. 2024 was C$0.00 Mil.

Nirvana Life Sciences Net Issuance of Preferred Stock Historical Data

The historical data trend for Nirvana Life Sciences's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nirvana Life Sciences Net Issuance of Preferred Stock Chart

Nirvana Life Sciences Annual Data

Trend

Oct18

Oct19

Oct20

Oct21

Apr22

Apr23

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Nirvana Life Sciences Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Nirvana Life Sciences Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Nirvana Life Sciences Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Nirvana Life Sciences's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Nirvana Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nirvana Life Sciences Inc (XCNQ:NIRV) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

650 West Georgia Street, Suite 2110, Vancouver, BC, CAN, V6B 4N8

Website

https://www.nirvanalifescience.com

Nirvana Life Sciences Inc is focused on developing medical products and regimens that address addiction. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.

Nirvana Life Sciences Headlines

No Headlines